Center for Neurodegeneration and Experimental Therapeutics (CNET)

CNET was established February 2, 2007 by UAB (following action taken by the Board of Trustees of the University of Alabama System) to promote the discovery of novel treatments for neurodegenerative disorders, to teach scientists and clinicians about these diseases, and to facilitate the application of these discoveries to clinical care of patients.

These neurodegenerative disorders include Alzheimer’s disease, Parkinson disease, Huntington disease, Amyotrophic Lateral Sclerosis (ALS, known as Lou Gehrig’s disease), and other less common neurodegenerative disorders that occur more frequently with advancing age.

	David G. Standaert, M.D., PhD. Director, Center for Neurodegeneration and Experimental Therapeutics John N. Whitaker Professor and Chair of Neurology Standaert Laboratory
	Michelle Gray, PhD Assistant Professor Dixon Scholar In Neuroscience Gray Laboratory
	Peter H. King, M.D. Professor Vice-Chair of Neurology Chief of Neurology, Birmingham VA Medical Center
	Liang Lu, M.D., Ph.D. Associate Professor
	Erik Roberson, M.D., Ph. D. Associate Professor Virginia B. Spencer Scholar in Neuroscience Roberson Laboratory
	Andrew West, Ph.D. Associate Professor John A. and Ruth R. Jurenko Research Scholar West Laboratory
	Talene Yacoubian, M.D., Ph.D. Assistant Professor Parkinson Associate of Alabama Scholar in Parkinson’s Research Yacoubian Laboratory